Literature DB >> 21742376

Core-shell NaYF4:Yb3+,Tm3+@FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node.

Ao Xia1, Yuan Gao, Jing Zhou, Chunyan Li, Tianshe Yang, Dongmei Wu, Limin Wu, Fuyou Li.   

Abstract

New core-shell structured NaYF(4):Yb(3+),Tm(3+)@Fe(x)O(y) nanocrystals, with 20 nm Yb(3+),Tm(3+)-co-doped NaYF(4) nanocrystals as a core and 5 nm Fe(x)O(y) nanocrystals as a shell, have been synthesized and characterized by TEM and XRD analysis. These core-shell nanocrystals exhibit excellent near-infrared upconversion luminescence (UCL) emission at 800 nm under excitation by a continuous-wave 980 nm laser and superparamagnetic properties with a saturation magnetization (Ms) of ∼12 emu/g. Water-soluble nanocrystals were obtained by surface ligand exchange of oleic acid-coated precursor nanocrystals, and their internalization within living cells has been investigated by laser scanning UCL microscopy. Furthermore, the obtained core-shell nanocrystals have been applied in dual-modality T(2)-enhanced magnetic resonance (MR) and UCL imaging in vivo of the lymphatic system. Moreover, the toxicity of NaYF(4):Yb(3+),Tm(3+)@Fe(x)O(y) nanocrystals has also been evaluated by MTT assay, IC50 values, and histological analysis of lymphatic node sections.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742376     DOI: 10.1016/j.biomaterials.2011.05.094

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  24 in total

Review 1.  Controlling upconversion nanocrystals for emerging applications.

Authors:  Bo Zhou; Bingyang Shi; Dayong Jin; Xiaogang Liu
Journal:  Nat Nanotechnol       Date:  2015-11       Impact factor: 39.213

Review 2.  Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research.

Authors:  F Chen; W Bu; W Cai; J Shi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 3.  Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Authors:  James Rieffel; Upendra Chitgupi; Jonathan F Lovell
Journal:  Small       Date:  2015-07-16       Impact factor: 13.281

Review 4.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

Review 5.  Upconversion nanoparticles: design, nanochemistry, and applications in theranostics.

Authors:  Guanying Chen; Hailong Qiu; Paras N Prasad; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2014-03-10       Impact factor: 60.622

6.  Synthesis and characterization of Na(Gd0.5Lu0.5)F4: Nd3+,a core-shell free multifunctional contrast agent.

Authors:  L Christopher Mimun; G Ajithkumar; Chris Rightsell; Brian W Langloss; Michael J Therien; Dhiraj K Sardar
Journal:  J Alloys Compd       Date:  2016-10-24       Impact factor: 5.316

7.  Nanoparticles for Improving Cancer Diagnosis.

Authors:  Hongmin Chen; Zipeng Zhen; Trever Todd; Paul K Chu; Jin Xie
Journal:  Mater Sci Eng R Rep       Date:  2013-03       Impact factor: 36.214

Review 8.  Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Dalong Ni; Wenbo Bu; Emily B Ehlerding; Weibo Cai; Jianlin Shi
Journal:  Chem Soc Rev       Date:  2017-11-27       Impact factor: 54.564

Review 9.  Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.

Authors:  Shameer Pillarisetti; Saji Uthaman; Kang Moo Huh; Yang Seok Koh; Sangjoon Lee; In-Kyu Park
Journal:  Tissue Eng Regen Med       Date:  2019-10-01       Impact factor: 4.169

10.  A multifunctional near-infrared fluorescent sensing material based on core-shell upconversion nanoparticles@magnetic nanoparticles and molecularly imprinted polymers for detection of deltamethrin.

Authors:  Ting Guo; Changchang Wang; Hongyuan Zhou; Yuhao Zhang; Liang Ma
Journal:  Mikrochim Acta       Date:  2021-04-15       Impact factor: 5.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.